|
"wang hw"的相關文件
顯示項目 1-10 / 57 (共6頁)
1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-09-17 |
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: long-term efficacy and biomarker exploration
|
Lin, YJ;Ou, DL;Su, YY;Hsu, CL;Hsiao, CF;Ko, BS;Chen, SC;Wang, HW;Wang, JH;Wu, YM;Jeng, YM;Lee, WC;Chou, SC;Chen, TW;Chiu, CF;Shiuan, L, Jr.;Hsieh, CH;Lee, CC;Shen, YS;Cheng, AL;Chen, LT;Hsu, C |
| 國家衛生研究院 |
2025-03-28 |
Recommendations and guidance for human papillomavirus (HPV) vaccination for adults in Taiwan
|
Lin, KY;Lin, IF;Wu, PF;Tsai, WC;Su, LY;Chang, CN;Huang, WH;Wang, CH;Hung, MC;Huang, CH;Chiu, NC;Cheng, MF;Hsieh, SM;Wang, NC;Lee, PI;Lu, CY;Wang, HW;Wong, SS;Lin, PC;Tsai, MH;Yang, SC;Hsu, YL;Lee, SS;Chen, YC;Wang, FD |
| 國家衛生研究院 |
2024-08-28 |
Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab
|
Shen, YC;Liu, TH;Nicholas, A;Soyama, A;Yuan, CT;Chen, TC;Eguchi, S;Yoshizumi, T;Itoh, S;Nakamura, N;Kosaka, H;Kaibori, M;Ishii, T;Hatano, E;Ogawa, C;Naganuma, A;Kakizaki, S;Cheng, CH;Lin, PT;Su, YY;Chuang, CH;Lu, LC;Wu, CJ;Wang, HW;Rau, KM;Hsu, CH;Lin, SM;Huang, YH;Hernandez, S;Finn, RS;Kudo, M;Cheng, AL |
| 國家衛生研究院 |
2023-11 |
Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome
|
Su, YY;Lin, YJ;Hsiao, CF;Ou, DL;Chen, SC;Wang, HW;Wang, JH;Wu, YM;Lee, WC;Chou, SC;Ho, CL;Chiu, CF;Chen, LT;Shen, YS;Cheng, AL;Hsu, C |
| 國家衛生研究院 |
2023-08 |
Mechanical transmission of dengue virus by Aedes aegypti may influence disease transmission dynamics during outbreaks
|
Li, HH;Su, MP;Wu, SC;Tsou, HH;Chang, MC;Cheng, YC;Tsai, KN;Wang, HW;Chen, GH;Tang, CK;Chung, PJ;Tsai, WT;Huang, LR;Yueh, YA;Chen, HW;Pan, CY;Akbari, OS;Chang, HH;Yu, GY;Marshall, JM;Chen, CH |
| 國家衛生研究院 |
2023-06 |
Atezolizumab plus bevacizumab for patients with unresectable hepatocellular carcinoma and high hepatitis B viral load: Focusing on hepatic safety and viral kinetics
|
Chen, SC;Tsou, HHS;Lee, TY;Wang, HW;Chen, YH;Wang, TE;Su, YY;Yang, S;Chiu, CF;Liu, TW;Cheng, AL;Chen, LT;Hsu, C |
| 國家衛生研究院 |
2023-02-17 |
CLEC5A mediates Zika virus-induced testicular damage
|
Wang, HW;Li, HH;Wu, SC;Tang, CK;Yu, HY;Chang, YC;Sung, PS;Liu, WL;Su, MP;Yu, GY;Huang, LR;Chen, CH;Hsieh, SL |
| 國家衛生研究院 |
2022-07 |
Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors
|
Su, YY;Lee, WH;Wang, JH;Wang, HW;Chen, TW;Chen, BB;Ho, HJ;Liu, TH;Chou, SC;Chen, BR;Liu, TW;Chen, LT;Wu, CY;Hsu, C |
| 國家衛生研究院 |
2020-01 |
Broad dengue neutralization in mosquitoes expressing an engineered antibody
|
Buchman, A;Gamez, S;Li, M;Antoshechkin, I;Li, HH;Wang, HW;Chen, CH;Klein, MJ;Duchemin, JB;Crowe, JE, Jr.;Paradkar, PN;Akbari, OS |
| 國家衛生研究院 |
2019-02-05 |
Engineered resistance to Zika virus in transgenic Aedes aegypti expressing a polycistronic cluster of synthetic small RNAs
|
Buchman, A;Gamez, S;Li, M;Antoshechkin, I;Li, HH;Wang, HW;Chen, CH;Klein, MJ;Duchemin, JB;Paradkar, PN;Akbari, OS |
顯示項目 1-10 / 57 (共6頁)
1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
|
